|
|
楼主 |
发表于 2025-2-21 00:22:58
|
显示全部楼层
马骏院士团队被接收一篇JAMA、一篇Cancer Cell，另有8项临床试验在进行中9 v( v* K; y1 P# r! k8 G
Whole-course Concurrent and Adjuvant Nivolumab Combined with Induction Chemotherapy Followed by Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma (NCT03984357, Cancer Cell, 2025,已接收)4 ?/ |) w% K" n- i& H l% w
8 T9 H N# Z$ r% M6 E- Y
Adjuvant PD-1 Antibody in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a Multi-center, Randomised Controlled, Phase 3 Trial (NCT03427827, JAMA, 2025,已接收)
: L+ w! z& w5 Q8 ~- c# {8 `1 D2 n, b9 X) ] h. R: N; [+ @$ P
GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma (NCT06455410, 进行中)# J2 p- l- f1 f, C3 Z! b0 r
Individualized Elective Neck Irradiation in NPC Patients (NCT06241612, 进行中)
2 p' ]5 B4 Q4 i- UReduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response (NCT06239727, 进行中)+ S) W8 G" _7 _! |7 c
Cadonilimab (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma (NCT05587374, 进行中): \* K3 F, ~! G7 A
TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT05563480, completed)5 r$ {* U, o) W9 m
Combining MRI and CEUS to Diagnose Small Cervical Lymph Node Metastases in NPC Patients (NPC-LN) (NCT05389306, 进行中)
# f+ ]& n' ^2 SMetronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma (NCT05342792, 进行中)/ N3 a& J3 i J
Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN) (NCT05044117, 进行中) |
|
发表于 2025-2-21 07:34:13
